Leading science, pioneering therapies

CRM Publications

Found 8 results
Filters: Keyword is Risk Factors  [Clear All Filters]
2014
Cubie HA, Canham MA, Moore C, Pedraza J, Graham C, Cuschieri K.  2014.  Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H).J Clin Pathol. 67(6):458-63.
2013
Heun R, Schoepf D, Potluri R, Natalwala A.  2013.  Alzheimer's disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up.Eur Psychiatry. 28(1):40-8.
Höiom V, Edsgärd D, Helgadottir H, Eriksson H, All-Ericsson C, Tuominen R, Ivanova I, Lundeberg J, Emanuelsson O, Hansson J.  2013.  Hereditary uveal melanoma: a report of a germline mutation in BAP1.Genes Chromosomes Cancer. 52(4):378-84.
2012
Schoepf D, Potluri R, Uppal H, Natalwala A, Narendran P, Heun R.  2012.  Type-2 diabetes mellitus in schizophrenia: increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up.Eur Psychiatry. 27(1):33-42.
2009
Potluri R, Natalwala A, Uppal H, Heun R.  2009.  Different risk factors in vascular dementia and ischaemic stroke.Neuroepidemiology. 32(1):80.
2008
Potluri R, Natalwala A, Uppal H, Heun R.  2008.  Cardiovascular risk factors in vascular dementia and ischaemic stroke.Neuroepidemiology. 31(1):67;discussion68.
2007
Bagnaninchi PO, Yang Y, Haj AJEl, Maffulli N.  2007.  Tissue engineering for tendon repair.Br J Sports Med. 41(8):e10;discussione10.
1996
Véniant M, Ménard J, Bruneval P, Morley S, Gonzales MF, Mullins JJ.  1996.  Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver.J Clin Invest. 98(9):1966-70.